Adv Pharm Bull. 2015;5(2): 151-159. doi: 10.15171/apb.2015.022
PMID: 26236652        PMCID: PMC4517084

Original Research

Solid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent Breakthroughs

Cited by CrossRef: 26

1- Vollrath M, Engert J, Winter G. Long-term release and stability of pharmaceutical proteins delivered from solid lipid implants. European Journal of Pharmaceutics and Biopharmaceutics. 2017;117:244 [Crossref]
2- Ezzati Nazhad Dolatabadi J, Omidi Y. Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems. TrAC Trends in Analytical Chemistry. 2016;77:100 [Crossref]
3- Bakhtiary Z, Barar J, Aghanejad A, Saei A, Nemati E, Ezzati Nazhad Dolatabadi J, Omidi Y. Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer. Drug Development and Industrial Pharmacy. 2017;43(8):1244 [Crossref]
4- Nemati E, Mokhtarzadeh A, Panahi-Azar V, Mohammadi A, Hamishehkar H, Mesgari-Abbasi M, Ezzati Nazhad Dolatabadi J, de la Guardia M. Ethambutol-Loaded Solid Lipid Nanoparticles as Dry Powder Inhalable Formulation for Tuberculosis Therapy. AAPS PharmSciTech . 2019;20(3) [Crossref]
5- Feng H, Zhu Y, Fu Z, Li D. Preparation, characterization, and in vivo study of rhein solid lipid nanoparticles for oral delivery. Chem Biol Drug Des. 2017;90(5):867 [Crossref]
6- Patel P, Agrawal Y. Targeting nanocarriers containing antisense oligonucleotides to cancer cell. Journal of Drug Delivery Science and Technology. 2017;37:97 [Crossref]
7- Hsu C, Wang P, Alalaiwe A, Lin Z, Fang J. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins. Nutrients. 2019;11(1):68 [Crossref]
8- Ghanbarzadeh S, Hariri R, Kouhsoltani M, Shokri J, Javadzadeh Y, Hamishehkar H. Enhanced stability and dermal delivery of hydroquinone using solid lipid nanoparticles. Colloids and Surfaces B: Biointerfaces. 2015;136:1004 [Crossref]
9- Kim J, Baek J, Park J, Lee B, Kim M, Hwang S, Lee J, Cho C. Development of Houttuynia cordata Extract-Loaded Solid Lipid Nanoparticles for Oral Delivery: High Drug Loading Efficiency and Controlled Release. Molecules. 2017;22(12):2215 [Crossref]
10- Zeeshan F, Tabbassum M, Jorgensen L, Medlicott N. Attenuated Total Reflection Fourier Transform Infrared (ATR FT-IR) Spectroscopy as an Analytical Method to Investigate the Secondary Structure of a Model Protein Embedded in Solid Lipid Matrices. Appl Spectrosc. 2018;72(2):268 [Crossref]
11- Jahanfar F, Hasani A, Shanebandi D, Rahmati M, Hamishehkar H. Enhanced in Vitro Anti-Tumor Activity of 5-Azacytidine by Entrapment into Solid Lipid Nanoparticles. Adv Pharm Bull. 2016;6(3):367 [Crossref]
12- Rahimpour Y, Javadzadeh Y, Hamishehkar H. Solid lipid microparticles for enhanced dermal delivery of tetracycline HCl. Colloids and Surfaces B: Biointerfaces. 2016;145:14 [Crossref]
13- Tupal A, Sabzichi M, Ramezani F, Kouhsoltani M, Hamishehkar H. Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer. Journal of Microencapsulation. 2016;33(4):372 [Crossref]
14- Escalona-Rayo O, Fuentes-Vázquez P, Leyva-Gómez G, Cisneros B, Villalobos R, Magaña J, Quintanar-Guerrero D. Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process. Drug Development and Industrial Pharmacy. 2017;43(6):871 [Crossref]
15- Soltani S, Rafiei A, Ramezani Z, Abbaspour M, Jelowdar A, Sagha Kahvaz M. Evaluation of the Hydatid Cyst Membrane Permeability of Albendazole and Albendazole Sulfoxide-Loaded Solid Lipid Nanoparticles. Jundishapur J Nat Pharm Prod. 2016;Inpress(Inpress) [Crossref]
16- Motawea A, Borg T, Abd El-Gawad A. Topical phenytoin nanostructured lipid carriers: design and development. Drug Development and Industrial Pharmacy. 2018;44(1):144 [Crossref]
17- Faustino C, Rijo P, Reis C. Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer’s disease. Pharmacological Research. 2017;120:68 [Crossref]
18- Rafiei A, Soltani S, Ramezani Z, Abbaspour M, Jelowdar A, Kahvaz M. Ultrastructural changes on fertile and infertile hydatid cysts induced by conventional and solid lipid nanoparticles of albendazole and albendazole sulfoxide. Comp Clin Pathol. 2019; [Crossref]
19- Lin C, Chen C, Lin Z, Fang J. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. Journal of Food and Drug Analysis. 2017;25(2):219 [Crossref]
20- Chang L, Hu J, Chen F, Chen Z, Shi J, Yang Z, Li Y, Lee L. Nanoscale bio-platforms for living cell interrogation: current status and future perspectives. Nanoscale. 2016;8(6):3181 [Crossref]
21- Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos A, Veiga F. RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opinion on Drug Delivery. 2018;15(10):965 [Crossref]
22- Tabbassum M, Zeeshan F. Effects of formulation development methods on the stability of model protein pharmaceuticals embedded in solid lipid matrices. Pharmaceutical Development and Technology. 2018;:1 [Crossref]
23- Motawea A, Abd El-Gawad A, Borg T, Motawea M, Tarshoby M. The Impact of Topical Phenytoin Loaded Nanostructured Lipid Carriers in Diabetic Foot Ulceration. The Foot. 2019; [Crossref]
24- Goh W, Zou S, Ong W, Torta F, Alexandra A, Schiffelers R, Storm G, Wang J, Czarny B, Pastorin G. Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative. Sci Rep. 2017;7(1) [Crossref]
25- Mardhiah Adib Z, Ghanbarzadeh S, Kouhsoltani M, Yari Khosroshahi A, Hamishehkar H. The Effect of Particle Size on the Deposition of Solid Lipid Nanoparticles in Different Skin Layers: A Histological Study. Adv Pharm Bull. 2016;6(1):31 [Crossref]
26- Islan G, Durán M, Cacicedo M, Nakazato G, Kobayashi R, Martinez D, Castro G, Durán N. Nanopharmaceuticals as a solution to neglected diseases: Is it possible?. Acta Tropica. 2017;170:16 [Crossref]
27- Madni A, Batool A, Noreen S, Maqbool I, Rehman F, Kashif P, Tahir N, Raza A. Novel nanoparticulate systems for lung cancer therapy: an updated review. Journal of Drug Targeting. 2017;25(6):499 [Crossref]
28- Yang J, Ciftci O. Formation of hollow solid lipid micro- and nanoparticles using supercritical carbon dioxide. Food and Bioproducts Processing. 2016;98:151 [Crossref]
29- Zeeshan F, Tabbassum M, Jorgensen L, Medlicott N. Investigation on Secondary Structure Perturbations of Proteins Embedded in Solid Lipid Matrices as a Novel Indicator of their Biological Activity upon In Vitro Release. AAPS PharmSciTech . 2018;19(2):769 [Crossref]
30- Abedi-Gaballu F, Dehghan G, Ghaffari M, Yekta R, Abbaspour-Ravasjani S, Baradaran B, Ezzati Nazhad Dolatabadi J, Hamblin M. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Applied Materials Today. 2018;12:177 [Crossref]
31- Soltani S, Rafiei A, Ramezani Z, Abbaspour M, Jelowdar A, Sagha Kahvaz M. Evaluation of the Hydatid Cyst Membrane Permeability of Albendazole and Albendazole Sulfoxide-Loaded Solid Lipid Nanoparticles. Jundishapur J Nat Pharm Prod. 2016;12(2) [Crossref]
32- Wang K, Chi C, Hu Z, Liu M, Hui H, Shang W, Peng D, Zhang S, Ye J, Liu H, Tian J. Optical Molecular Imaging Frontiers in Oncology: The Pursuit of Accuracy and Sensitivity. Engineering. 2015;1(3):309 [Crossref]
33- Oliveira M, Aryasomayajula B, Pattni B, Mussi S, Ferreira L, Torchilin V. Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models. International Journal of Pharmaceutics. 2016;512(1):292 [Crossref]

Journal Info

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 
Freq.: Quarterly


Quick link

Editorial Board


Platinum Open Access

(no submission or publication fees)


Powered by